CD79A and B-cell chronic lymphocytic leukemia: By evaluating VDJ regions across all three samples we observed >99% of all B cells (CD79A+) sequenced contained identical VDJ sequences, confirming the RT-phase tumor in this patient derived as a clonal progression from the existing CLL (Supplemental Fig. 1A).